Prevalence and implications of bilateral and solely contralateral lymph node metastases in oral squamous cell carcinoma.

These findings provide valuable insights for surgeons considering contralateral ND or extended adjuvant treatment for OSCC patients. However, the absence of high-level evidence from randomized controlled trials impedes the establishment of a definitive standard of care.